Search:
You do not have permission to access this chart.
Please Sign Up or Login
News for Avenue Therapeutics, Inc. (ATXI)
minutes ago | Banggood.com
58 minutes ago | Aliexpress.com
2 months ago | GlobeNewsWire
3 months ago | Newsfile Corp
3 months ago | Zacks Investment Research
4 months ago | Pulse2
4 months ago | GlobeNewsWire
4 months ago | Pulse2
8 months ago | GlobeNewsWire
8 months ago | GlobeNewsWire
10 months ago | Zacks Investment Research
10 months ago | Benzinga
Avenue Therapeutics, Inc., a specialty pharmaceutical company, acquires, licenses, develops, and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, which is in Phase III clinical trials to treat moderate to moderately severe post-operative pain. The company was incorporated in 2015 and is based in New York, New York.
Sector:
HealthcareIndustry:
BiotechnologyEmployees:
4Address:
Avenue Therapeutics, Inc. 1140 Avenue of the America 9th Floor New York NY 10036 United StatesWebsite:
About